Get the Stockscreener App
14.25
0.78%
0.11
After Hours:
14.09
-0.16
-1.12%
Inmode Ltd stock is traded at $14.25, with a volume of 660.87K.
It is up +0.78% in the last 24 hours and up +5.24% over the past month.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
See More
Previous Close:
$14.14
Open:
$14.2
24h Volume:
660.87K
Relative Volume:
0.62
Market Cap:
$902.86M
Revenue:
$370.50M
Net Income/Loss:
$93.83M
P/E Ratio:
9.8527
EPS:
1.4463
Net Cash Flow:
$89.39M
1W Performance:
+3.41%
1M Performance:
+5.24%
6M Performance:
-6.68%
1Y Performance:
-7.50%
1-Day Range:
$13.98
$14.28
1-Week Range:
$13.35
$14.28
52-Week Range:
$12.72
$16.74
Inmode Ltd Stock (INMD) Company Profile
Compare INMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INMD
Inmode Ltd
|
14.25 | 895.89M | 370.50M | 93.83M | 89.39M | 1.4463 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-29-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-28-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-17-24 | Initiated | BTIG Research | Buy |
| Jul-23-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-03-23 | Downgrade | UBS | Buy → Neutral |
| Oct-13-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-29-23 | Initiated | UBS | Buy |
| Feb-17-23 | Downgrade | Needham | Buy → Hold |
| Dec-21-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| May-18-21 | Initiated | Needham | Buy |
| Sep-03-19 | Initiated | Barclays | Overweight |
| Sep-03-19 | Initiated | Canaccord Genuity | Buy |
| Sep-03-19 | Initiated | Robert W. Baird | Outperform |
| Sep-03-19 | Initiated | UBS | Buy |
View All
Inmode Ltd Stock (INMD) Latest News
CCORF Maintains InMode(INMD.US) With Hold Rating, Maintains Target Price $15 - Moomoo
InMode: The Beauty Of A Value Trap (NASDAQ:INMD) - Seeking Alpha
InMode Flags Slow Aesthetic Demand, Picofy-Driven Q1 Lift and Margin Pressure at Needham Conference - Yahoo Finance
InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M - The Malaysian Reserve
InMode Ltd. (NASDAQ:INMD) Rating Update Draws Nasdaq Today Attention - Kalkine Media
Press Release: InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M - Moomoo
Needham Maintains InMode(INMD.US) With Hold Rating - Moomoo
(INMD) InMode Expects 2026 Revenue Range $365M$375M, vs. FactSet Est of $369.6M - marketscreener.com
InMode Ltd. (NASDAQ:INMD) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
(INMD) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Market Catalysts: Is InMode Ltd a top pick in the sector2026 Volatility Report & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Michael Kreindel Discloses Investment in InMode with 5.11% Stake - TradingView — Track All Markets
Insider Moshe Mizrahy boosts InMode (NASDAQ: INMD) stake to 7.06% amid buybacks - Stock Titan
InMode (INMD) CTO Michael Kreindel discloses 5.11% beneficial stake via 13D - Stock Titan
InMode expects Q1 sales below estimates - MSN
Movement Recap: Whats the RSI of InMode Ltd stock2026 Dividend Review & Daily Oversold Bounce Ideas - baoquankhu1.vn
Layoff Watch: Is InMode Ltd stock a good pick for beginnersWeekly Market Outlook & Verified Short-Term Plans - baoquankhu1.vn
Hedge Fund Moves: Can InMode Ltd deliver consistent dividends2026 Volume & AI Enhanced Trading Alerts - baoquankhu1.vn
INMD SEC FilingsInmode Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan
InMode Ltd. (INMD) stock price, news, quote and history - Yahoo Finance UK
InMode Ltd Stock: Innovative Aesthetic Devices Driving Growth in a Competitive Medical Tech Landscap - AD HOC NEWS
InMode Ltd. Experiences Revision in Stock Evaluation Amid Market Volatility and Performance Challenges - Markets Mojo
INMD Stock Price, Quote & Chart | INMODE LTD (NASDAQ:INMD) - ChartMill
Recap Report: Will InMode Ltd outperform tech stocks2026 Bull vs Bear & Weekly High Conviction Trade Ideas - baoquankhu1.vn
JPMorgan Chase & Co. Has $9.61 Million Stake in InMode Ltd. $INMD - MarketBeat
InMode Ltd. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
Aug Drivers: Can InMode Ltd deliver consistent dividends2026 AllTime Highs & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
InMode to Present at the 25th Annual Needham Virtual Healthcare Conference - Sahm
InMode CEO, CFO to appear in Needham virtual conference chat - Stock Titan
InMode Ltd Stock Faces Headwinds Amid Slowing Demand in Aesthetic Devices Market - AD HOC NEWS
InMode sets new share repurchase program - MSN
Insider Sell: Is InMode Ltd stock a good pick for beginners2026 Historical Comparison & Risk Managed Investment Entry Signals - baoquankhu1.vn
InMode board approves buyback covering nearly 10% of stock - MSN
Rate Hike: What is the target price for InMode Ltd stock2026 Geopolitical Influence & Consistent Income Trade Ideas - baoquankhu1.vn
(INMD) Movement as an Input in Quant Signal Sets - Stock Traders Daily
InMode Ltd. (NASDAQ:INMD) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Do Options Traders Know Something About InMode Stock We Don't? - MSN
InMode Ltd Stock (ISIN: IL0011356806) Faces Headwinds Amid Medtech Sector Slowdown and Revenue Press - AD HOC NEWS
InMode CFO Sees Demand Stabilizing, Targets Flat 2026 Revenue as North America Rebuild Begins - MarketBeat
InMode Details Israel Disruptions, 60% Capacity and $600M Buyback Plans at Oppenheimer Conference - MarketBeat
InMode Ltd. (NASDAQ: INMD) Q4 2025 earnings call transcript - MSN
InMode (INMD) director Michael Anghel details initial share and RSU stake - Stock Titan
InMode (INMD) CEO Moshe Mizrahy discloses 4,299,226 ordinary shares in Form 3 - Stock Titan
InMode (INMD) director Kenneth Nadav discloses initial share and RSU stake - Stock Titan
InMode (INMD) CTO Michael Kreindel discloses 3.1M-share insider stake - Stock Titan
InMode (INMD) CFO discloses shares, options and RSUs in Form 3 - Stock Titan
InMode (INMD) North America president reports ordinary share and RSU holdings - Stock Titan
InMode (INMD) director Ron Hadar reports Form 3 share holdings - Stock Titan
InMode at Oppenheimer Conference: Strategic Shifts Amid Challenges By Investing.com - in.investing.com
InMode at Oppenheimer Conference: Strategic Shifts Amid Challenges - Investing.com South Africa
Short Interest in InMode Ltd. (NASDAQ:INMD) Decreases By 14.9% - MarketBeat
Inmode Ltd Stock (INMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):